Acanthamoeba Keratitis
📧 Sign up to get email alerts when something new happens for Acanthamoeba Keratitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Retrospective Chart Review of Patients With Acanthamoeba Keratitis Who Have Received 0.8 mg/mL Polihexanide as Part of the "Medicines in Special Situations" (Medicamentos en Situaciones Especiales) Program in Spain.
A retrospective chart review protocol evaluating 0.8 mg/mL polyhexanide for Acanthamoeba keratitis under Spain's Medicines in Special Situat…
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction [Phase 3]
Phase 3 clinical trial evaluating Rose Bengal with green light for infection reduction in Acanthamoeba keratitis and fungal keratitis has co…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Parasitic Ulcer Treatment Trial [Phase 3]
A Phase 3 clinical trial investigating a treatment for Acanthamoeba keratitis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: Retrospective Chart Review of Patients With Acanthamoeba Keratitis Who Have Received 0.8 mg/ml Polihexanide
A retrospective chart review of outcomes for patients with Acanthamoeba keratitis treated with 0.8 mg/mL polyhexanide.
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Evaluation of Resveratrol and Its Loaded Nanoparticles on Acanthamoeba
Assiut University is evaluating resveratrol and resveratrol-loaded nanoparticles for Acanthamoeba keratitis, a corneal infection. The trial …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Ultrahigh-resolution Optical Coherence Tomography Imaging of the Anterior Eye Segment Structures [NA]
A completed clinical trial from the Medical University of Vienna evaluated ultrahigh-resolution optical coherence tomography imaging of ante…
-
EMA approval · 2024-11-29EMA Authorised: Akantior (Polihexanide) — SIFI SPA
The European Medicines Agency authorised Akantior (polihexanide) from SIFI SPA for the treatment of Acanthamoeba keratitis. It has orphan me…
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: Acanthamoeba and Artificial Intelligence
A trial update involving Acanthamoeba Keratitis with an artificial intelligence component; the status is unknown.
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: Parasitic Ulcer Treatment Trial Pilot [Phase 2]
Phase 2 pilot trial update for a parasitic ulcer treatment targeting Acanthamoeba keratitis.
-
CLINICAL_TRIALS trial_result · 2023-08-02Clinical Trial Update: Polihexanide (PHMB) Eye Drops in Patients Affected by Acanthamoeba Keratitis [Phase 3]
Phase 3 clinical trial evaluating Polihexanide (PHMB) eye drops for Acanthamoeba Keratitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-11-23Clinical Trial Update: Safety and Tolerability of Preservative-free Polyhexamethylene Biguanide (PHMB) Ophthalmic Solution in Healthy Subjects [Phase 1]
Phase 1 study evaluating the safety and tolerability of preservative-free Polyhexamethylene Biguanide (PHMB) ophthalmic solution in healthy …
-
CLINICAL_TRIALS research · 2016-05-09Clinical Trial Update: Retrospective Study of Acanthamoebic Keratitis During the Past 10 Years
Retrospective clinical study evaluating acanthamoebic keratitis cases over the past decade.